Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | +11.69% | +12.15% | -25.00% |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 31/10/20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 07/09/21 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 30/04/14 |
Alan Walts
BRD | Director/Board Member | 64 | 31/03/21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Lindsay Androski
BRD | Director/Board Member | - | 04/07/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.00% | 2.66M | |
-2.19% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.84% | 16.05B | |
+5.02% | 13.68B | |
+36.41% | 12.17B |
- Stock Market
- Equities
- ELOX Stock
- Company Eloxx Pharmaceuticals, Inc.